Compare RKLB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKLB | DGX |
|---|---|---|
| Founded | 2006 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.0B | 20.5B |
| IPO Year | N/A | 1996 |
| Metric | RKLB | DGX |
|---|---|---|
| Price | $49.33 | $182.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | $50.38 | ★ $194.07 |
| AVG Volume (30 Days) | ★ 18.8M | 1.2M |
| Earning Date | 11-10-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | N/A | ★ 14.49 |
| EPS | N/A | ★ 8.51 |
| Revenue | $554,535,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $40.19 | $12.37 |
| Revenue Next Year | $48.56 | $3.52 |
| P/E Ratio | ★ N/A | $21.44 |
| Revenue Growth | ★ 52.42 | 13.74 |
| 52 Week Low | $14.71 | $148.70 |
| 52 Week High | $73.97 | $197.55 |
| Indicator | RKLB | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 52.46 | 44.87 |
| Support Level | $39.98 | $184.18 |
| Resistance Level | $43.59 | $185.12 |
| Average True Range (ATR) | 2.92 | 3.22 |
| MACD | 1.10 | -0.78 |
| Stochastic Oscillator | 95.43 | 3.85 |
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.